Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
2740 |
issn |
1744-7666 1465-6566 |
issueIdentifier |
15 |
pageRange |
2727-2740 |
publicationName |
Expert Opinion on Pharmacotherapy |
startingPage |
2727 |
bibliographicCitation |
Dell'Osso B, Allen A, Hollander E. Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder. Expert Opin Pharmacother. 2005 Dec;6(15):2727–40. doi: 10.1517/14656566.6.15.2727. PMID: 16316311. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b99beead4053f368556fbb304c45e67b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4f59b32bfb98c0c80a31a0aec89bc77 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e3c919d06a99b3c4070e9942c7a052b |
date |
2005-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1517/14656566.6.15.2727 https://pubmed.ncbi.nlm.nih.gov/16316311 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22235 https://portal.issn.org/resource/ISSN/1744-7666 https://portal.issn.org/resource/ISSN/1465-6566 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder |
discusses |
http://id.nlm.nih.gov/mesh/M0025397 http://id.nlm.nih.gov/mesh/M0026372 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5324346 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8681 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43815 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2995 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2801 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6923 |